We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's What Key Metrics Tell Us About Dentsply (XRAY) Q1 Earnings
Read MoreHide Full Article
For the quarter ended March 2024, Dentsply International (XRAY - Free Report) reported revenue of $953 million, down 2.6% over the same period last year. EPS came in at $0.42, compared to $0.39 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $969.84 million, representing a surprise of -1.74%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.42.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Dentsply performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Organic sales growth: -1.9% compared to the -0.5% average estimate based on five analysts.
Revenues- United States: $356 million compared to the $350.20 million average estimate based on three analysts. The reported number represents a change of +1.4% year over year.
Revenues- Rest of World: $221 million versus $231.08 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -4.3% change.
Revenues- Europe: $376 million compared to the $386.89 million average estimate based on three analysts. The reported number represents a change of -5.1% year over year.
Net sales- Connected Technology Solutions: $247 million compared to the $253.92 million average estimate based on five analysts. The reported number represents a change of -54.9% year over year.
Net sales- Wellspect Healthcare: $71 million versus $71.80 million estimated by five analysts on average.
Net sales- Essential Dental Solutions: $364 million compared to the $377.32 million average estimate based on five analysts.
Net sales- Orthodontic and Implant Solutions: $271 million versus the five-analyst average estimate of $266.79 million.
Adjusted Operating Income- Connected Technology Solutions: $2 million versus $21.25 million estimated by two analysts on average.
Adjusted Operating Income- Wellspect Healthcare: $23 million versus the two-analyst average estimate of $19.39 million.
Adjusted Operating Income- Orthodontic and Implant Solutions: $42 million versus $42.40 million estimated by two analysts on average.
Adjusted Operating Income- Essential Dental Solutions: $115 million versus $124.87 million estimated by two analysts on average.
Shares of Dentsply have returned -5.2% over the past month versus the Zacks S&P 500 composite's -4.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's What Key Metrics Tell Us About Dentsply (XRAY) Q1 Earnings
For the quarter ended March 2024, Dentsply International (XRAY - Free Report) reported revenue of $953 million, down 2.6% over the same period last year. EPS came in at $0.42, compared to $0.39 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $969.84 million, representing a surprise of -1.74%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.42.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Dentsply performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Organic sales growth: -1.9% compared to the -0.5% average estimate based on five analysts.
- Revenues- United States: $356 million compared to the $350.20 million average estimate based on three analysts. The reported number represents a change of +1.4% year over year.
- Revenues- Rest of World: $221 million versus $231.08 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -4.3% change.
- Revenues- Europe: $376 million compared to the $386.89 million average estimate based on three analysts. The reported number represents a change of -5.1% year over year.
- Net sales- Connected Technology Solutions: $247 million compared to the $253.92 million average estimate based on five analysts. The reported number represents a change of -54.9% year over year.
- Net sales- Wellspect Healthcare: $71 million versus $71.80 million estimated by five analysts on average.
- Net sales- Essential Dental Solutions: $364 million compared to the $377.32 million average estimate based on five analysts.
- Net sales- Orthodontic and Implant Solutions: $271 million versus the five-analyst average estimate of $266.79 million.
- Adjusted Operating Income- Connected Technology Solutions: $2 million versus $21.25 million estimated by two analysts on average.
- Adjusted Operating Income- Wellspect Healthcare: $23 million versus the two-analyst average estimate of $19.39 million.
- Adjusted Operating Income- Orthodontic and Implant Solutions: $42 million versus $42.40 million estimated by two analysts on average.
- Adjusted Operating Income- Essential Dental Solutions: $115 million versus $124.87 million estimated by two analysts on average.
View all Key Company Metrics for Dentsply here>>>Shares of Dentsply have returned -5.2% over the past month versus the Zacks S&P 500 composite's -4.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.